Maven Securities’s Verona Pharma VRNA Stock Holding History

Maven Securities’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-80,000	Closed	-$8.54M	–	561
2025 Q3	$8.54M	Buy	+80,000	New	+$8.35M	0.21%	101

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Maven Securities's VRNA Position: Q4 2025 in Review

Maven Securities sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 80,000 shares — an estimated $8.54M sold.

Maven Securities first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $8.54M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Maven Securities reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Maven Securities sold 80,000 Verona Pharma shares in Q4 2025, an estimated $8.54M.
Maven Securities first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Maven Securities's Verona Pharma position peaked at $8.54M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Maven Securities's 13F filing for Q4 2025, filed 13 Feb 2026.